Data Integrity module
Feb 21 2018 Read 4296 Times
LabWare has developed and launched a new data integrity module for its enterprise LIMS and ELN solution to help drug manufacturers conform to the FDA draft guidance on ‘Data Integrity and Compliance with CGMP’.
The new enhancement to LabWare LIMS & ELN ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO), which would require the capture of temporary data in electronic records.
The new features are in addition to LabWare current solution that supports a GxP-compliant audit trail based on a full history of analytical testing, including:
Forced Save during manual result entry, to mitigate manipulation of values in temporary memory.
Disabling manual entry when data is captured directly from instrumentation
Forced reviews of Audit Trail entries when exceptions occur, such as result modification
Checksum generation and checking against data records, to detect manipulation.
Date time of data entry
Electronic Signature and mandatory reason for change
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...
View all digital editions
Apr 23 2019 Moscow, Russia
Apr 30 2019 Chicago, IL, USA
Apr 30 2019 Ricoh Arena, Coventry, UK
May 05 2019 St. Louis, MO, USA
May 13 2019 Fort Worth, Tx, USA